The first-ever drug regimen to blunt acute peanut allergies in children should be approved, experts told a Food and Drug Administration committee Friday, because the therapy has the potential to reduce the risk of life-threatening reactions and improve patients’ lives. The new drug, called Palforzia and made by Aimmune Therapeutics, is an oral immunotherapy regimen that aims to reduce sensitivity to peanut allergens. It gradually exposes children to small amounts of peanut protein over the course of six months, until they can safety eat the equivalent of two peanuts. But the treatment does not work for everyone and is accompanied by side effects, including severe allergic reactions to the peanut exposure. Twenty percent of the children in the trial who received the treatment withdrew because of adverse events; 14 percent had severe allergic reactions that required treatment with epinephrine, compared with only 6.5 percent who received a placebo. The regimen begins with trace amounts of the protein that are carefully measured and increased incrementally under medical supervision as tolerance develops. The goal is not to cure the allergy but to reduce the risk that an accidental exposure to a small amount of peanut will trigger a life-threatening reaction. It might… Read full this story
- Experimental treatment could reduce kids’ peanut allergies
- Researchers Tout Possible Breakthrough on Curing Peanut Allergies
- Greenwich Village doctor says new study on peanut allergies was done 'extraordinarily well'
- Odwalla Chocolate Protein Monster recalled; four customers with peanut allergies experienced severe allergic reactions
- Girl with peanut allergy dies after eating peanut butter-laced dessert at summer camp
- Life-threatening peanut allergy compels woman to leave University of Washington
- Safe Social Media: Children's networking sites like Everloop protect children from predators
- Arizona to let drug companies do what the FDA forbids
- Morning sickness drug Diclegis gains approval by FDA after similar version was pulled from shelves 30 years ago
- Kentucky can't ignore social services 'time bomb,' experts tell reform panel
Peanut allergy drug will protect children, experts tell FDA have 329 words, post on www.bostonglobe.com at September 13, 2019. This is cached page on USA Breaking News. If you want remove this page, please contact us.